- $9.88bn
- $10.06bn
- $4.89bn
- 91
- 57
- 57
- 77
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,087 | 4,169 | 4,289 | 4,577 | 4,888 |
Cost of Revenue | |||||
Gross Profit | 1,434 | 1,413 | 1,478 | 1,619 | 1,728 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,517 | 3,574 | 3,464 | 3,902 | 4,234 |
Operating Profit | 570 | 595 | 825 | 675 | 654 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 568 | 583 | 814 | 648 | 636 |
Provision for Income Taxes | |||||
Net Income After Taxes | 479 | 498 | 688 | 550 | 543 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 479 | 498 | 688 | 550 | 541 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 476 | 494 | 681 | 542 | 532 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.47 | 3.71 | 3.83 | 4.37 | 5 |
Dividends per Share |